Enlivex Therapeutics Ltd. Ordinary Shares $0.9197
Market Capitalization:
$221.69M
Enlivex Therapeutics Price Chart Enlivex Therapeutics Price Chart 2:39 PM 3:59 PM 5:19 PM 6:39 PM 7:59 PM 5:19 AM 6:39 AM 0.9197 0.9051 0.8906 0.8760 0.8614 0.8469 0.83
Enlivex Therapeutics Volume Chart Enlivex Therapeutics Volume Chart 2:39 PM 3:59 PM 5:19 PM 6:39 PM 7:59 PM 5:19 AM 6:39 AM 10.60K 9.09K 7.57K 6.06K 4.54K 3.03K 1.51K Enlivex Therapeutics Market Segments Premarket +0.0550(+6.36%)
Open $0.8647 Close $0.9197 Low $0.8640 Low Change -0.0007 (-0.08%) High $0.9198 High Change +0.0551 (+6.37%) Range $0.0558 Volume 1.574K Dollar Volume $1.45K
After Hours Yesterday +0.0000(+0.00%)
Open $0.8480 Close $0.8480 Low $0.8480 Low Change 0.0000 (0.00%) High $0.8480 High Change +0.0000 (+0.00%) Range $0.0000 Volume 250 Dollar Volume $212.00
Regular Trading Hours Yesterday -0.0330(-3.79%)
Open $0.8700 Close $0.8370 Low $0.8266 Low Change -0.0434 (-4.99%) High $0.9000 High Change +0.0300 (+3.45%) Range $0.0734 Volume 304.9K Dollar Volume $255.20K
Premarket Yesterday +0.0200(+2.27%)
Open $0.8800 Close $0.9000 Low $0.8800 Low Change 0.0000 (0.00%) High $0.9000 High Change +0.0200 (+2.27%) Range $0.0200 Volume 660 Dollar Volume $594.00
Enlivex Therapeutics Moving Averages 5 Day Moving Average (SMA5) $0.8871 10 Day Moving Average (SMA10) $0.8733 20 Day Moving Average (SMA20) $0.8898 50 Day Moving Average (SMA50) $1.0197 100 Day Moving Average (SMA100) $0.9966 200 Day Moving Average (SMA200) $1.0634
Enlivex Therapeutics Statistics Average Volume (30 Days) 879.1K P/E Ratio (Current) -17.60 EPS (Current) -$0.05 Dividend Yield 0.00% Free Cash Flow -$7.19M Cash Ratio 1.30 Current Ratio 1.85 Quick Ratio 1.85 Debt to Equity 0.00 Enterprise Value $206.45M EV to EBITDA -20.29 EV to Sales — Price to Book 5.98 Price to Cash Flow — Price to Free Cash Flow — Price to Sales — Return on Assets -0.29% Return on Equity -0.33%
Enlivex Therapeutics Stock Splits There have been 2 stock splits for Enlivex Therapeutics (ENLV). The last reverse stock split occured on March 6, 2019 and reduced the outstanding shares at a ratio of 8:1.
Date Type Ratio Mar 6, 2019 Reverse 8:1 Sep 25, 2017 Reverse 5:1
Enlivex Therapeutics Dividends There have been no dividends for Enlivex Therapeutics (ENLV).